In conclusion, our study provides clear evidence that the ELA/APJ axis exerts beneficial effects on diabetic glomerular endothelial injury by regulating the AMPK/NLRP3 signaling pathway, highlighting the potential therapeutic implications of modulating this signaling pathway for the treatment of DKD. The gene discussed is NLRP3; the disease is diabetic kidney disease.